Company intelligence
CubicBio
Biotechnology Research
2 employees
2 public signals
Verified activity
Signals from CubicBio
2 published signals
Research & Knowledge
CubicBio published a 2026 older-human cohort study showing short-term rapamycin treatment altered immune and inflammatory markers but failed to reset the epigenetic biological clock.
Reported by Ramon Coronado Schmilinski M.S., Ph.D.
Research & Knowledge
CubicBio published a new Cell Reports study by Huang et al. (2026) that uses scRNA-seq and scATAC-seq on PBMCs from healthy donors spanning mid-fetal development through old age to show immune aging mechanisms.
Reported by Ramon Coronado Schmilinski M.S., Ph.D.